Increlex

Increlex, synonymous with mecasermin, is a recombinant human insulin-like growth factor-1 (IGF-1) used for treating growth failure in children with severe primary IGF-1 deficiency. This condition results from inadequate IGF-1 production, crucial for growth. Administered via subcutaneous injection, Increlex stimulates growth pathways, aiding in bone and tissue development. It’s essential for patients unresponsive to growth hormone therapy, necessitating careful healthcare monitoring due to potential side effects like hypoglycemia, ensuring safe and effective treatment outcomes.

Select Wishlist

    Left Menu Icon
    Your Cart